**Core Concept**
The question is testing the knowledge of cancer management and survival outcomes in various malignancies. The underlying principle is the impact of advances in medical treatment on patient survival.

**Why the Correct Answer is Right**
The correct answer is related to the significant improvement in survival rates achieved through targeted therapies and immunotherapies in certain types of cancer. For instance, the introduction of tyrosine kinase inhibitors (TKIs) and checkpoint inhibitors has revolutionized the treatment of certain cancers, leading to improved survival outcomes. This is particularly evident in the management of **chronic myeloid leukemia (CML)**, where TKIs have dramatically increased the survival rate.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because, while advances in cancer treatment have improved survival rates in various malignancies, the specific improvement in survival rate is not as pronounced as in the case of CML.

**Option B:** This option is incorrect because, although there have been significant advances in the treatment of breast cancer, the survival rate improvement is not as dramatic as in the case of CML.

**Option C:** This option is incorrect because, while there have been improvements in the treatment of lung cancer, the survival rate improvement is not as pronounced as in the case of CML.

**Option D:** This option is incorrect because, although there have been advances in the treatment of lymphomas, the survival rate improvement is not as dramatic as in the case of CML.

**Clinical Pearl / High-Yield Fact**
The development of targeted therapies and immunotherapies has transformed the management of certain cancers, leading to significant improvements in survival rates. It is essential to stay updated on the latest advances in cancer treatment to provide optimal care for patients.

**Correct Answer:** A. Chronic myeloid leukemia (CML)